Article Details
Retrieved on: 2018-09-06 18:59:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Bridgewater Associates</b> LP raised its position in Valeant Pharmaceuticals (NYSE:VRX) (TSE:VRX) by 255.2% during the 2nd quarter, according to the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here